Guardant Health Quarterly Balance Sheets Chart
Quarterly
|
Annual
Guardant Health Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||
| cash and cash equivalents | 629,143,000 | 698,572,000 | 525,540,000 | 688,368,000 | 1,035,239,000 | 1,129,257,000 | 1,133,537,000 | 457,339,000 | 271,073,000 | 223,640,000 | 141,647,000 | 158,310,000 | 215,169,000 | 573,604,000 | 492,202,000 | 832,370,000 | 938,590,000 | 869,372,000 | 832,977,000 | 142,945,000 | 164,671,000 | 152,239,000 | 143,228,000 | 147,188,000 | 174,653,000 | 153,790,000 | 140,544,000 | 113,957,000 |
| short-term marketable securities | 314,438,000 | 310,701,000 | 35,097,000 | 697,482,000 | 953,776,000 | 713,380,000 | 869,584,000 | 799,727,000 | 638,521,000 | 388,662,000 | 440,546,000 | 653,601,000 | 853,072,000 | 1,071,078,000 | 961,903,000 | 870,459,000 | 773,160,000 | 367,853,000 | 379,574,000 | 375,768,000 | 370,974,000 | 313,069,000 | 278,417,000 | 157,385,000 | ||||
| accounts receivable | 130,252,000 | 115,426,000 | 110,253,000 | 88,465,000 | 100,519,000 | 84,562,000 | 88,783,000 | 88,801,000 | 86,468,000 | 87,204,000 | 97,256,000 | 86,200,000 | 95,276,000 | 84,331,000 | 97,652,000 | 60,744,000 | 53,667,000 | 48,039,000 | 53,299,000 | 36,255,000 | 41,017,000 | 48,015,000 | 47,986,000 | 39,689,000 | 40,363,000 | 28,989,000 | 35,690,000 | 14,640,000 |
| inventory | 84,061,000 | 77,256,000 | 71,083,000 | 72,298,000 | 66,984,000 | 62,991,000 | 61,948,000 | 77,036,000 | 60,529,000 | 46,474,000 | 51,598,000 | 63,047,000 | 59,890,000 | 36,613,000 | 30,674,000 | 24,739,000 | 26,494,000 | 28,876,000 | 22,716,000 | 27,731,000 | 20,354,000 | 25,148,000 | 15,181,000 | 14,760,000 | 14,176,000 | 10,256,000 | 9,136,000 | 7,075,000 |
| prepaid expenses and other current assets | 39,976,000 | 35,772,000 | 33,800,000 | 66,883,000 | 87,232,000 | 31,736,000 | 27,741,000 | 26,239,000 | 25,809,000 | 33,762,000 | 31,509,000 | 23,565,000 | 28,283,000 | 30,070,000 | 53,052,000 | 21,958,000 | 19,236,000 | 15,679,000 | 17,466,000 | 9,898,000 | 11,101,000 | 14,137,000 | 11,389,000 | 5,657,000 | 4,082,000 | 6,151,000 | 5,204,000 | 4,024,000 |
| total current assets | 883,432,000 | 927,026,000 | 1,055,114,000 | 1,226,715,000 | 1,289,974,000 | 1,308,546,000 | 1,347,106,000 | 1,346,897,000 | 1,397,655,000 | 1,104,460,000 | 1,191,594,000 | 1,130,849,000 | 1,037,139,000 | 1,113,280,000 | 1,114,126,000 | 1,593,412,000 | 1,891,059,000 | 2,033,044,000 | 1,888,361,000 | 1,087,288,000 | 1,010,303,000 | 607,392,000 | 597,358,000 | 583,062,000 | 604,248,000 | 512,255,000 | 468,991,000 | 297,081,000 |
| restricted cash | 106,337,000 | 105,281,000 | 104,215,000 | |||||||||||||||||||||||||
| property and equipment | 126,141,000 | 129,294,000 | 136,813,000 | 125,169,000 | 132,317,000 | 138,387,000 | 145,096,000 | 147,671,000 | 155,741,000 | 163,229,000 | 167,920,000 | 168,007,000 | 163,362,000 | 151,322,000 | 124,461,000 | 106,156,000 | 89,737,000 | 71,765,000 | 62,782,000 | 61,882,000 | 56,995,000 | 46,685,000 | 43,668,000 | 40,759,000 | 34,811,000 | 30,581,000 | 31,003,000 | 30,318,000 |
| right-of-use assets | 169,768,000 | 140,500,000 | 142,265,000 | 144,964,000 | 146,111,000 | 151,881,000 | 157,616,000 | 161,668,000 | 165,273,000 | 170,651,000 | 174,001,000 | 178,747,000 | 183,703,000 | 188,607,000 | 189,443,000 | 196,436,000 | 200,958,000 | 205,671,000 | 37,343,000 | 36,103,000 | 38,503,000 | 30,132,000 | 29,140,000 | |||||
| intangible assets | 5,864,000 | 6,280,000 | 6,760,000 | 7,251,000 | 7,742,000 | 8,294,000 | 8,979,000 | 9,670,000 | 10,361,000 | 11,047,000 | 11,727,000 | 12,417,000 | 13,108,000 | 13,727,000 | 14,207,000 | 14,698,000 | 15,189,000 | 15,674,000 | 16,155,000 | 16,645,000 | 17,148,000 | 17,681,000 | 8,524,000 | 8,755,000 | 8,987,000 | |||
| goodwill | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 3,290,000 | 2,928,000 | 2,935,000 | |||
| other assets | 37,167,000 | 32,555,000 | 37,152,000 | 31,338,000 | 29,906,000 | 94,200,000 | 124,334,000 | 128,035,000 | 107,697,000 | 58,954,000 | 61,453,000 | 51,728,000 | 70,560,000 | 70,919,000 | 60,938,000 | 61,316,000 | 36,284,000 | 17,297,000 | 17,208,000 | 5,453,000 | 5,124,000 | 4,721,000 | 4,882,000 | 3,073,000 | 3,159,000 | 2,862,000 | 2,046,000 | 1,936,000 |
| total assets | 1,331,999,000 | 1,344,226,000 | 1,485,609,000 | 1,538,727,000 | 1,609,340,000 | 1,704,598,000 | 1,786,421,000 | 1,797,231,000 | 1,840,017,000 | 1,511,631,000 | 1,609,985,000 | 1,701,779,000 | 1,853,737,000 | 2,129,598,000 | 2,204,499,000 | 2,225,534,000 | 2,291,885,000 | 2,346,741,000 | 2,271,781,000 | 1,262,109,000 | 1,277,536,000 | 948,167,000 | 962,535,000 | 948,334,000 | 939,989,000 | 579,171,000 | 587,403,000 | 344,599,000 |
| liabilities and stockholders’ deficit | ||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||
| accounts payable | 44,802,000 | 49,770,000 | 38,551,000 | 15,473,000 | 42,447,000 | 37,603,000 | 40,911,000 | 36,971,000 | 32,230,000 | 17,580,000 | 15,674,000 | 21,399,000 | 22,318,000 | 7,340,000 | 18,281,000 | 15,982,000 | 24,378,000 | 16,197,000 | 12,054,000 | 15,700,000 | 7,163,000 | 10,642,000 | 13,081,000 | |||||
| accrued compensation | 68,262,000 | 63,678,000 | 83,219,000 | 80,647,000 | 59,067,000 | 92,639,000 | 57,423,000 | 38,672,000 | 56,158,000 | 42,496,000 | 38,838,000 | 34,735,000 | 37,180,000 | 28,280,000 | 24,037,000 | 18,526,000 | 22,935,000 | 18,557,000 | 24,604,000 | 13,687,000 | 14,683,000 | 12,986,000 | 7,430,000 | |||||
| accrued expenses | 71,011,000 | 76,003,000 | 68,345,000 | 71,671,000 | 70,680,000 | 67,211,000 | 63,367,000 | 77,157,000 | 51,851,000 | 45,285,000 | 40,475,000 | 31,998,000 | 27,643,000 | 22,639,000 | 22,312,000 | 24,055,000 | 23,073,000 | 25,703,000 | 17,239,000 | 11,092,000 | 9,137,000 | 7,081,000 | 7,482,000 | |||||
| deferred revenue | 54,355,000 | 36,302,000 | 35,468,000 | 29,554,000 | 29,375,000 | 22,556,000 | 17,965,000 | 21,485,000 | 12,237,000 | 13,621,000 | 17,403,000 | 13,423,000 | 14,955,000 | 10,570,000 | 11,326,000 | 7,317,000 | 8,480,000 | 8,360,000 | 8,550,000 | 7,337,000 | 11,485,000 | 11,936,000 | 12,277,000 | 13,095,000 | 16,496,000 | 17,113,000 | 16,138,000 | 3,955,000 |
| total current liabilities | 238,430,000 | 225,753,000 | 225,583,000 | 197,345,000 | 201,569,000 | 220,009,000 | 205,917,000 | 226,751,000 | 200,933,000 | 204,155,000 | 193,220,000 | 175,124,000 | 167,755,000 | 228,809,000 | 194,687,000 | 102,304,000 | 96,612,000 | 95,501,000 | 66,809,000 | 71,967,000 | 70,048,000 | 82,322,000 | 72,734,000 | 67,817,000 | 57,049,000 | 48,192,000 | 46,944,000 | 32,050,000 |
| convertible senior notes, net, principal amount of 1,090,660 and 1,150,000 as of june 30, 2025 and december 31, 2024, respectively | 1,115,526,000 | |||||||||||||||||||||||||||
| long-term operating lease liabilities | 192,348,000 | 160,378,000 | 164,292,000 | 170,131,000 | 172,194,000 | 178,907,000 | 185,848,000 | 192,677,000 | 198,230,000 | 204,857,000 | 210,015,000 | 216,174,000 | 221,503,000 | 225,377,000 | 226,053,000 | 216,806,000 | 211,783,000 | 210,244,000 | 41,565,000 | 39,682,000 | 41,117,000 | 33,773,000 | 33,256,000 | |||||
| other long-term liabilities | 91,170,000 | 92,545,000 | 92,834,000 | 89,446,000 | 95,934,000 | 96,786,000 | 96,006,000 | 10,182,000 | 9,450,000 | 9,136,000 | 9,179,000 | 6,988,000 | 9,287,000 | 6,909,000 | 3,933,000 | 3,424,000 | 2,486,000 | 1,651,000 | 1,520,000 | 1,856,000 | 1,382,000 | 1,459,000 | 1,672,000 | 1,220,000 | 1,303,000 | 150,000 | 206,000 | 206,000 |
| total liabilities | 1,637,474,000 | 1,595,015,000 | 1,625,256,000 | 1,598,823,000 | 1,610,953,000 | 1,636,313,000 | 1,627,737,000 | 1,568,932,000 | 1,547,291,000 | 1,556,182,000 | 1,549,805,000 | 1,535,034,000 | 1,534,650,000 | 1,596,558,000 | 1,559,494,000 | 1,456,714,000 | 1,444,420,000 | 1,440,295,000 | 916,186,000 | 113,505,000 | 112,547,000 | 117,554,000 | 114,542,000 | 86,438,000 | 77,715,000 | 64,537,000 | 62,451,000 | 47,462,000 |
| commitments and contingencies | ||||||||||||||||||||||||||||
| stockholders’ deficit: | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||
| common stock | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||||
| treasury stock | -45,010,000 | -45,010,000 | ||||||||||||||||||||||||||
| additional paid-in capital | 2,516,550,000 | 2,472,272,000 | 2,443,788,000 | 2,410,416,000 | 2,363,501,000 | 2,329,930,000 | 2,304,220,000 | 2,188,797,000 | 2,169,911,000 | 1,763,544,000 | 1,716,075,000 | 1,703,832,000 | 1,682,406,000 | 1,626,926,000 | 1,597,419,000 | 1,557,954,000 | 1,601,188,000 | 1,544,373,000 | 1,157,945,000 | 771,009,000 | ||||||||
| accumulated other comprehensive loss | -3,723,000 | -4,658,000 | -5,201,000 | -3,284,000 | -5,640,000 | -4,799,000 | -3,675,000 | -5,680,000 | -8,469,000 | -12,150,000 | -26,852,000 | -24,261,000 | -18,314,000 | 333,000 | ||||||||||||||
| accumulated deficit | -2,773,293,000 | -2,673,394,000 | -2,578,235,000 | -2,467,229,000 | -2,359,475,000 | -2,256,847,000 | -2,141,862,000 | -1,954,819,000 | -1,868,717,000 | -1,795,946,000 | -1,522,479,000 | -1,360,485,000 | -1,131,053,000 | -916,914,000 | -809,388,000 | -711,813,000 | -512,847,000 | -435,177,000 | -380,538,000 | -303,209,000 | ||||||||
| total stockholders’ deficit | -305,475,000 | -250,789,000 | ||||||||||||||||||||||||||
| total liabilities and stockholders’ deficit | 1,331,999,000 | 1,344,226,000 | ||||||||||||||||||||||||||
| convertible senior notes, net, principal amount of 1,090,660 and 1,150,000 as of march 31, 2025 and december 31, 2024, respectively | 1,116,339,000 | |||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||
| liabilities and stockholders’ equity | ||||||||||||||||||||||||||||
| convertible senior notes | 1,142,547,000 | 1,141,901,000 | 1,141,256,000 | 1,140,611,000 | 1,139,966,000 | 1,139,322,000 | 1,138,678,000 | 1,138,034,000 | 1,137,391,000 | 1,136,748,000 | 1,136,105,000 | 1,135,463,000 | 1,134,821,000 | 1,134,180,000 | 1,133,539,000 | 1,132,899,000 | 806,292,000 | |||||||||||
| stockholders’ equity | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2024 and 2023 | ||||||||||||||||||||||||||||
| total stockholders’ equity | -139,647,000 | 68,285,000 | 158,684,000 | 228,299,000 | 292,726,000 | 166,745,000 | 319,087,000 | 533,040,000 | 709,420,000 | 788,065,000 | 847,046,000 | 1,092,204,000 | 1,114,589,000 | 785,113,000 | 468,134,000 | |||||||||||||
| total liabilities and stockholders’ equity | 1,485,609,000 | 1,704,598,000 | 1,786,421,000 | 1,797,231,000 | 1,840,017,000 | 1,701,779,000 | 1,853,737,000 | 2,129,598,000 | ||||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||
| total stockholders’ (deficit) equity | -60,096,000 | -1,613,000 | -44,551,000 | |||||||||||||||||||||||||
| total liabilities and stockholders’ (deficit) equity | 1,538,727,000 | 1,609,340,000 | 1,511,631,000 | |||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||
| accounts payable and accrued liabilities | 187,952,000 | 205,266,000 | 188,696,000 | 190,534,000 | 175,817,000 | |||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2023 and 2022 | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||
| liabilities and stockholders’ (deficit) equity | ||||||||||||||||||||||||||||
| stockholders’ (deficit) equity: | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||
| long-term marketable debt securities | 156,741,000 | |||||||||||||||||||||||||||
| noncontrolling interest liability | 78,000,000 | 78,000,000 | ||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||
| long-term marketable securities | 382,575,000 | 588,453,000 | 698,034,000 | 250,226,000 | 55,368,000 | 246,597,000 | 51,398,000 | 146,118,000 | 238,206,000 | 268,783,000 | 302,624,000 | 277,301,000 | 25,916,000 | 77,563,000 | 2,963,000 | |||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||
| preferred stock, par value of 0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||
| liabilities, redeemable noncontrolling interest and stockholders’ equity | ||||||||||||||||||||||||||||
| redeemable noncontrolling interest | 59,400,000 | 59,400,000 | 59,400,000 | 56,400,000 | 50,400,000 | 45,500,000 | 49,600,000 | 46,500,000 | 46,800,000 | 46,500,000 | 41,800,000 | 41,950,000 | ||||||||||||||||
| accumulated other comprehensive income | -593,000 | 33,000 | 904,000 | 3,862,000 | 5,392,000 | 7,705,000 | ||||||||||||||||||||||
| total liabilities, redeemable noncontrolling interest and stockholders’ equity | 2,225,534,000 | 2,291,885,000 | 2,346,741,000 | 1,262,109,000 | 1,277,536,000 | 948,167,000 | 579,171,000 | |||||||||||||||||||||
| capitalized license fees | 45,000 | 50,000 | 55,000 | 60,000 | 6,890,000 | 7,133,000 | 7,313,000 | 7,557,000 | 7,800,000 | 8,044,000 | ||||||||||||||||||
| obligation related to royalty | 6,880,000 | 6,780,000 | 7,136,000 | 7,120,000 | 7,338,000 | 7,446,000 | ||||||||||||||||||||||
| deferred rent, net of current portion | 10,564,000 | 10,912,000 | 8,975,000 | 7,844,000 | 7,623,000 | |||||||||||||||||||||||
| capital lease, current | 80,000 | 74,000 | 96,000 | 97,000 | 102,000 | |||||||||||||||||||||||
| deferred rent, current | 745,000 | |||||||||||||||||||||||||||
| capital lease, net of current portion | 57,000 | 80,000 | 100,000 | 119,000 | 137,000 | |||||||||||||||||||||||
| deferred tax assets | 1,235,000 | |||||||||||||||||||||||||||
| deferred tax liabilities | 1,235,000 | |||||||||||||||||||||||||||
| deferred offering costs | 4,257,000 |
We provide you with 20 years of balance sheets for Guardant Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Guardant Health. Explore the full financial landscape of Guardant Health stock with our expertly curated balance sheets.
The information provided in this report about Guardant Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.